Epivios GmbH, a Düsseldorf, Germany-based developer of molecular diagnostic cancer tests as a spin-off of the Heinrich Heine University of Düsseldorf. Its interdisciplinary team, comprising doctors and biologists, has been working since 2009 on innovative epigenetic procedures for cancer diagnosis.